Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy—given before and after surgery—significantly improved event-free survival (EFS) in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results